Acadia Healthcare Company Inc (NASDAQ:ACHC) currently trades at $38.39 which is about -1.61% lower than the 52-week high of $65.00. The trading volume at ready counter moved to 649,583.00 shares as compared to 1.25M shares average traded volume. The stock failed to get pushed above the $38.65 barrier, the intraday high, after opening at $38.30. Analysts have a consensus target price of $52.00 in the 12-month period. Its market capitalization has now reached to $3.30B.

Acadia Healthcare Company Inc (NASDAQ:ACHC) was dropped to Underweight from Equal Weight at Barclays. It has earned a consensus Strong buy rating, according to Zacks Investment Research. No analyst has rated the stock with a sell rating, 1 has assigned a hold rating, 1 says it’s a buy and 12 have assigned a strong buy rating to the company.

Acadia Healthcare Company Inc (ACHC) on November 10, 2016 announced that the Competition and Markets Authority (“CMA”) in the United Kingdom has accepted Acadia’s previously announced undertakings to sell to BC Partners 21 existing behavioral health facilities and one de novo behavioral health facility not yet opened, which are located in the U.K. The sale will fulfill the undertakings Acadia gave the CMA to address the CMA’s concerns about the impact of Acadia’s acquisition of Priory on competition for the provision of behavioral healthcare services in certain markets in the U.K. As a result of the CMA’s acceptance of Acadia’s undertakings, Acadia’s acquisition of Priory will not be referred for an in-depth phase 2 investigation.

Acadia expects to complete the sale on November 30, 2016, for £320 million (approximately $390 million) cash. The facilities to be sold have approximately 1,000 total beds and produce aggregate approximate annual revenue of $162 million and adjusted EBITDA of $37 million, after overhead allocation and assuming an exchange rate of $1.22 per British Pound Sterling.